Advanced Science · 2022 · 201 citations · 23 references
PharmacyNeurosciencePharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryBlood-brain Barrier PenetrationDrug EncapsulationMagnetic NanomaterialsNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsGlioblastoma Drug TherapyGlioblastoma Targeted TherapyGlutathione Peroxidase 4Localized Magnetic TargetingMagnetic Drug Delivery SystemsMagnetic LocalizationMagnetic Nanoparticle Drug DeliveryMagnetic Nanoparticles
Abstract Glioblastoma (GBM) is one of the most fatal central nervous system tumors and lacks effective or sufficient therapies. Ferroptosis is a newly discovered method of programmed cell death and opens a new direction for GBM treatment. However, poor blood–brain barrier (BBB) penetration, reduced tumor targeting ability, and potential compensatory mechanisms hinder the effectiveness of ferroptosis agents during GBM treatment. Here, a novel composite therapeutic platform combining the magnetic targeting features and drug delivery properties of magnetic nanoparticles with the BBB penetration abilities and siRNA encapsulation properties of engineered exosomes for GBM therapy is presented. This platform can be enriched in the brain under local magnetic localization and angiopep‐2 peptide‐modified engineered exosomes can trigger transcytosis, allowing the particles to cross the BBB and target GBM cells by recognizing the LRP‐1 receptor. Synergistic ferroptosis therapy of GBM is achieved by the combined triple actions of the disintegration of dihydroorotate dehydrogenase and the glutathione peroxidase 4 ferroptosis defense axis with Fe 3 O 4 nanoparticle‐mediated Fe 2+ release. Thus, the present findings show that this system can serve as a promising platform for the treatment of glioblastoma.
23
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell · 2012 · 18.1K citations · Full text
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Lydia Alvarez‐Erviti, Yiqi Seow, HaiFang Yin et al. · Nature Biotechnology · 2011 · 4.8K citations
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Chao Mao, Xiaoguang Liu, Yilei Zhang et al. · Nature · 2021 · 1.8K citations · Full text